Postnatal steroids in extreme preterm infants: Intra-tracheal instillation using surfactant as a vehicle

Area of Science:

• Neonatology
• Pediatric Pulmonology
• Developmental Neuroscience

Background:

• Chronic Lung Disease (CLD) is a significant respiratory complication in extremely preterm infants.
• CLD is linked to long-term adverse neurodevelopmental outcomes.
• Early lung inflammation is a key factor in CLD development.

Purpose of the Study:

• To review the evidence for tracheal steroid instillation as a potential treatment for CLD.
• To evaluate the efficacy and safety of steroids delivered via surfactant in preterm infants.
• To explore the role of early lung inflammation in CLD pathogenesis.

Main Methods:

• Review of published data on steroid distribution via tracheal instillation with surfactant.
• Analysis of in vitro physical studies on the delivery vehicle.
• Examination of clinical trial data from animal models and human infants.

Main Results:

• Systemic steroids reduce CLD incidence but cause neurodevelopmental issues.
• Inhaled steroid efficacy for CLD is not yet established.
• Tracheal instillation of steroids with surfactant is being investigated for improved drug delivery and safety.

Conclusions:

• Tracheal instillation of steroids using surfactant warrants further investigation.
• This delivery method may offer a safer alternative to systemic steroids for preventing CLD.
• Optimizing early lung inflammation management is crucial for preterm infant outcomes.